Notice Type
Departmental
Notice Title

Renewal of Provisional Consent to the Distribution of Medicines

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Rilutek
Riluzole 50mg
Tablet
sanofi-aventis new zealand limited
Sanofi Winthrop Industrie, Compiegne, France

Note: This consent is given subject to the following condition:

Rilutek can only be prescribed by specialist physicians who care for patients with Motor Neurone Disease, neurologists and palliative care physicians.

Note: This renewed consent is valid for two years from 4 April 2015.

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Verorab
Rabies vaccine, Wistar PM/WI 38-1503-3M 2.5IU
Powder for injection with diluent
sanofi-aventis new zealand limited
Sanofi Pasteur SA, Val-De-Reuil Cedex, France
Sanofi Pasteur SA, Marcy L’Etoile, France
Catalent Belgium SA, Brussels, Belgium

Note: This renewed consent is valid for two years from 27 January 2015.

Dated this 3rd day of December 2014.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).